Rho-kinase inhibition during early cardiac development causes arrhythmogenic right ventricular cardiomyopathy in mice

Alia Ellawindy, Kimio Satoh, Shinichiro Sunamura, Nobuhiro Kikuchi, Kota Suzuki, Tatsuro Minami, Shohei Ikeda, Shinichi Tanaka, Toru Shimizu, Budbazar Enkhjargal, Satoshi Miyata, Yuhto Taguchi, Tetsuya Handoh, Kenta Kobayashi, Kazuto Kobayashi, Keiko Nakayama, Masahito Miura, Hiroaki Shimokawa

研究成果: Article査読

18 被引用数 (Scopus)

抄録

Objective-Arrhythmogenic right ventricular cardiomyopathy (ARVC) is characterized by fibrofatty changes of the right ventricle, ventricular arrhythmias, and sudden death. Though ARVC is currently regarded as a disease of the desmosome, desmosomal gene mutations have been identified only in half of ARVC patients, suggesting the involvement of other associated mechanisms. Rho-kinase signaling is involved in the regulation of intracellular transport and organizes cytoskeletal filaments, which supports desmosomal protein complex at the myocardial cell'cell junctions. Here, we explored whether inhibition of Rho-kinase signaling is involved in the pathogenesis of ARVC. Approach and Results-Using 2 novel mouse models with SM22α-or αMHC-restricted overexpression of dominantnegative Rho-kinase, we show that mice with Rho-kinase inhibition in the developing heart (SM22α-restricted) spontaneously develop cardiac dilatation and dysfunction, myocardial fibrofatty changes, and ventricular arrhythmias, resulting in premature sudden death, phenotypes fulfilling the criteria of ARVC in humans. Rho-kinase inhibition in the developing heart results in the development of ARVC phenotypes in dominant-negative Rho-kinase mice through 3 mechanisms: (1) reduction of cardiac cell proliferation and ventricular wall thickness, (2) stimulation of the expression of the proadipogenic noncanonical Wnt ligand, Wnt5b, and the major adipogenic transcription factor, PPARγ (peroxisome proliferator activated receptor-γ), and inhibition of Wnt/β-catenin signaling, and (3) development of desmosomal abnormalities. These mechanisms lead to the development of cardiac dilatation and dysfunction, myocardial fibrofatty changes, and ventricular arrhythmias, ultimately resulting in sudden premature death in this ARVC mouse model. Conclusions-This study demonstrates a novel crucial role of Rho-kinase inhibition during cardiac development in the pathogenesis of ARVC in mice.

本文言語English
ページ(範囲)2172-2184
ページ数13
ジャーナルArteriosclerosis, thrombosis, and vascular biology
35
10
DOI
出版ステータスPublished - 2015 10 25

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

フィンガープリント 「Rho-kinase inhibition during early cardiac development causes arrhythmogenic right ventricular cardiomyopathy in mice」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル